Immutep (IMMP) Interest Coverage Ratio (2015 - 2023)

Immutep (IMMP) posted Interest Coverage Ratio of 0.07 for Q4 2023, up 100.05% on a QoQ basis from 143.84 in Q2 2016.

Immutep (IMMP) Interest Coverage Ratio (2015 - 2023) Analysis & Trends

Immutep's Interest Coverage Ratio history runs 3 years deep, the most recent figure standing at 0.07 for Q4 2023.

Quarterly Interest Coverage Ratio changed N/A year-over-year to 0.07 in Q4 2023, while the trailing twelve-month figure through Dec 2024 was 0.18 (up 67.05% YoY) and the FY2025 annual result came in at 1655.89, down 8.81% from the prior year.
Interest Coverage Ratio was 0.07 for Q4 2023 at Immutep, up from 143.84 in the prior quarter.
Across five years, Interest Coverage Ratio topped out at 0.07 in Q4 2023 and bottomed at 0.07 in Q4 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	658.42
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-157.58
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	7.60
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	2.71
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	22.72
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-0.38
10	Immutep	569.08 Mn	569.08 Mn	-	-

Historic Data

Download Data

Date	Value
Dec 31, 2023	0.07
Jun 30, 2016	-143.84
Jun 30, 2015	0.00